Hunt T, Amit Z
Neurosci Biobehav Rev. 1987 Spring;11(1):107-30. doi: 10.1016/s0149-7634(87)80005-2.
In this paper we have reviewed the literature on Conditioned Taste Aversion (CTA) with specific attention to the "apparent paradox" in this literature. This paradox refers to the fact that drugs which are self-administered (SA) by animals and are therefore presumed to possess positive reinforcing properties are also endowed with the capacity to induce a CTA. We have argued that the CTA literature contains evidence of the existence of two qualitatively distinct types of CTA, one which is mediated by emetic agents and the other induced by SA drugs. We first provided evidence to support the notion that the traditional explanation of CTA as a function of "drug toxicity" and its resultant gastrointestinal distress does not fit the data on the nature of CTA induced by SA drugs. We proposed instead that "drug shyness" or the novelty of the drug state of these psychoactive SA drugs constitutes a better explanation of the CTA of SA drugs. We provided further evidence suggesting a functional relationship between the positive reinforcing and aversive properties of SA drugs. We have based this contention on a review of the behavioral, physiological and neurochemical data concerning the nature of CTA of SA drugs. The examination of these data reveals that the neural mechanisms underlying both the positive and aversive properties of SA drugs are the same and at the same time different from the neural mechanisms underlying the induction of CTA by emetic agents. Finally, we discussed the relevance of this interaction between the positive and aversive properties of SA drugs in the context of their abuse liability and the control they exert on drug-oriented behavior.
在本文中,我们回顾了关于条件性味觉厌恶(CTA)的文献,特别关注了该文献中的“明显悖论”。这个悖论指的是,动物会自我给药(SA)的药物,因此被认为具有正强化特性,同时也具备诱导CTA的能力。我们认为,CTA文献中有证据表明存在两种性质不同的CTA,一种由催吐剂介导,另一种由SA药物诱导。我们首先提供证据支持以下观点:传统上将CTA解释为“药物毒性”及其导致的胃肠道不适的函数,并不符合关于SA药物诱导的CTA本质的数据。相反,我们提出“药物回避”或这些精神活性SA药物的药物状态的新奇性,能更好地解释SA药物的CTA。我们进一步提供证据,表明SA药物的正强化和厌恶特性之间存在功能关系。我们基于对有关SA药物CTA本质的行为、生理和神经化学数据的回顾提出了这一论点。对这些数据的研究表明,SA药物的正性和负性特性背后的神经机制是相同的,同时又不同于催吐剂诱导CTA背后的神经机制。最后,我们在SA药物的滥用倾向及其对药物相关行为的控制背景下,讨论了SA药物正性和负性特性之间这种相互作用的相关性。